OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Evaluating enrollment and outcome criteria in trials of biologics for chronic rhinosinusitis with nasal polyps
Larry Borish, Noah Cohen, Geoffrey Chupp, et al.
Annals of Allergy Asthma & Immunology (2022) Vol. 129, Iss. 2, pp. 160-168
Open Access | Times Cited: 23
Larry Borish, Noah Cohen, Geoffrey Chupp, et al.
Annals of Allergy Asthma & Immunology (2022) Vol. 129, Iss. 2, pp. 160-168
Open Access | Times Cited: 23
Showing 23 citing articles:
Chronic Rhinosinusitis with Nasal Polyps and Biologics: A Call for Better Data Standardisation and Presentation in Clinical Studies
Harsha H. Kariyawasam, Dean Langan, Joanne Rimmer
Therapeutics and Clinical Risk Management (2025) Vol. Volume 21, pp. 27-34
Open Access | Times Cited: 2
Harsha H. Kariyawasam, Dean Langan, Joanne Rimmer
Therapeutics and Clinical Risk Management (2025) Vol. Volume 21, pp. 27-34
Open Access | Times Cited: 2
Switching of biological therapy to dupilumab in comorbid patients with severe asthma and CRSwNP
Cecilia Rosso, Eugenio De Corso, Valerio Conti, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 6, pp. 3017-3023
Open Access | Times Cited: 12
Cecilia Rosso, Eugenio De Corso, Valerio Conti, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 6, pp. 3017-3023
Open Access | Times Cited: 12
Efficacy and safety of CM310 in severe eosinophilic chronic rhinosinusitis with nasal polyps (CROWNS-1): a multicentre, randomised, double-blind, placebo-controlled phase 2 clinical trial
Yuan Zhang, Bing Yan, Shen Shen, et al.
EClinicalMedicine (2023) Vol. 61, pp. 102076-102076
Open Access | Times Cited: 22
Yuan Zhang, Bing Yan, Shen Shen, et al.
EClinicalMedicine (2023) Vol. 61, pp. 102076-102076
Open Access | Times Cited: 22
The Unified Airway Hypothesis: Evidence From Specific Intervention With Anti–IL-5 Biologic Therapy
Claus Bachert, Amber Luong, Philippe Gevaert, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 9, pp. 2630-2641
Open Access | Times Cited: 21
Claus Bachert, Amber Luong, Philippe Gevaert, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 9, pp. 2630-2641
Open Access | Times Cited: 21
Biologics for Chronic Rhinosinusitis—A Modern Option for Therapy
Romică Cergan, Ovidiu Berghi, Mihai Dumitru, et al.
Life (2023) Vol. 13, Iss. 11, pp. 2165-2165
Open Access | Times Cited: 19
Romică Cergan, Ovidiu Berghi, Mihai Dumitru, et al.
Life (2023) Vol. 13, Iss. 11, pp. 2165-2165
Open Access | Times Cited: 19
Outcome measures for chronic rhinosinusitis with nasal polyps
Ahmad R. Sedaghat, Raewyn G. Campbell, Richard Douglas, et al.
Rhinology Journal (2024)
Open Access | Times Cited: 4
Ahmad R. Sedaghat, Raewyn G. Campbell, Richard Douglas, et al.
Rhinology Journal (2024)
Open Access | Times Cited: 4
Biological therapy in Chronic rhinosinusitis with nasal polyps
Zeyi Jin, Bing Yan, Luo Zhang, et al.
Expert Review of Clinical Immunology (2025)
Closed Access
Zeyi Jin, Bing Yan, Luo Zhang, et al.
Expert Review of Clinical Immunology (2025)
Closed Access
Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design
Lucía De Prado Gómez, Asif Khan, Anju T. Peters, et al.
American Journal of Rhinology and Allergy (2022) Vol. 36, Iss. 6, pp. 788-795
Closed Access | Times Cited: 16
Lucía De Prado Gómez, Asif Khan, Anju T. Peters, et al.
American Journal of Rhinology and Allergy (2022) Vol. 36, Iss. 6, pp. 788-795
Closed Access | Times Cited: 16
Differential nasal swab cytology represents a valuable tool for therapy monitoring but not prediction of therapy response in chronic rhinosinusitis with nasal polyps treated with Dupilumab
Zeynep Danisman, Maximilian Linxweiler, Jan Philipp Kühn, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Zeynep Danisman, Maximilian Linxweiler, Jan Philipp Kühn, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?
Dorien Van Broeck, Brecht Steelant, Glenis Scadding, et al.
Frontiers in Allergy (2023) Vol. 4
Open Access | Times Cited: 7
Dorien Van Broeck, Brecht Steelant, Glenis Scadding, et al.
Frontiers in Allergy (2023) Vol. 4
Open Access | Times Cited: 7
'Efficacy of biologics in NSAID-ERD: United airways from the nose to the bronchi'
Kathleen M. Buchheit, Elke Vandewalle, Hester Beatrice Emilie Elzinga, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 11, pp. 2917-2932
Closed Access | Times Cited: 2
Kathleen M. Buchheit, Elke Vandewalle, Hester Beatrice Emilie Elzinga, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 11, pp. 2917-2932
Closed Access | Times Cited: 2
Current goals of NSAID-ERD management: patient-centered approaches involving NSAID desensitization with and without biologics
Irina Bobolea, Jan Hagemann, Marek Sanak, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 11, pp. 2934-2944
Open Access | Times Cited: 2
Irina Bobolea, Jan Hagemann, Marek Sanak, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 11, pp. 2934-2944
Open Access | Times Cited: 2
Perspectives in Therapy of Chronic Rhinosinusitis
Jacek Brzost, Katarzyna Czerwaty, Karolina Dżaman, et al.
Diagnostics (2022) Vol. 12, Iss. 10, pp. 2301-2301
Open Access | Times Cited: 9
Jacek Brzost, Katarzyna Czerwaty, Karolina Dżaman, et al.
Diagnostics (2022) Vol. 12, Iss. 10, pp. 2301-2301
Open Access | Times Cited: 9
Core Outcome Measures in Chronic Rhinosinusitis With Nasal Polyps: In Practice and Research
Alaaeldein Abdulghany, Pavol Šurda, Claire Hopkins
American Journal of Rhinology and Allergy (2023) Vol. 37, Iss. 2, pp. 232-239
Closed Access | Times Cited: 4
Alaaeldein Abdulghany, Pavol Šurda, Claire Hopkins
American Journal of Rhinology and Allergy (2023) Vol. 37, Iss. 2, pp. 232-239
Closed Access | Times Cited: 4
Eosinophil Peroxidase: A Biomarker for Eosinophilic Chronic Rhinosinusitis Agnostic of Polyp Status
Beau M. Idler, Koji Iijima, Sergei I. Ochkur, et al.
The Laryngoscope (2023) Vol. 134, Iss. 1, pp. 69-78
Closed Access | Times Cited: 4
Beau M. Idler, Koji Iijima, Sergei I. Ochkur, et al.
The Laryngoscope (2023) Vol. 134, Iss. 1, pp. 69-78
Closed Access | Times Cited: 4
Current Understanding of the Role of Eosinophils in CRSwNP and Implications for Treatment with Mepolizumab and Benralizumab
A. Simon Carney, Peter Smith
American Journal of Rhinology and Allergy (2023) Vol. 37, Iss. 2, pp. 175-181
Closed Access | Times Cited: 2
A. Simon Carney, Peter Smith
American Journal of Rhinology and Allergy (2023) Vol. 37, Iss. 2, pp. 175-181
Closed Access | Times Cited: 2
Hat die ASS-Desaktivierung in Zeiten von Biologika noch einen Stellenwert bei chronischer Rhinosinusitis mit nasaler Polyposis?
Felix Klimek, Ulrike Förster‐Ruhrmann, Jan Hagemann, et al.
HNO (2024) Vol. 72, Iss. 7, pp. 484-493
Closed Access
Felix Klimek, Ulrike Förster‐Ruhrmann, Jan Hagemann, et al.
HNO (2024) Vol. 72, Iss. 7, pp. 484-493
Closed Access
Efectividad real de la terapia biológica en el tratamiento de pacientes con rinosinusitis crónica con poliposis nasosinusal
Cristina García-García, Ithzel María Villarreal, Adriana Pardo-Maza, et al.
Revista ORL (2024) Vol. 15, Iss. 2, pp. e31902-e31902
Open Access
Cristina García-García, Ithzel María Villarreal, Adriana Pardo-Maza, et al.
Revista ORL (2024) Vol. 15, Iss. 2, pp. e31902-e31902
Open Access
Impacto do uso de corticosteroides intranasais no manejo de rinossinusite crônica
Luiz Henrique Santos, Miguel Silveira, Giulia Gabrielly de Lima, et al.
Brazilian Journal of Implantology and Health Sciences (2024) Vol. 6, Iss. 8, pp. 3673-3681
Open Access
Luiz Henrique Santos, Miguel Silveira, Giulia Gabrielly de Lima, et al.
Brazilian Journal of Implantology and Health Sciences (2024) Vol. 6, Iss. 8, pp. 3673-3681
Open Access
Mepolizumab for the treatment of chronic rhinosinusitis with nasal polyps in adults
Josh Neposlan, Leigh J. Sowerby, Ameen Biadsee
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 2, pp. 109-118
Closed Access
Josh Neposlan, Leigh J. Sowerby, Ameen Biadsee
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 2, pp. 109-118
Closed Access
Biologic therapies in atopic diseases
Jonathan Corren
Annals of Allergy Asthma & Immunology (2022) Vol. 129, Iss. 2, pp. 129-130
Open Access
Jonathan Corren
Annals of Allergy Asthma & Immunology (2022) Vol. 129, Iss. 2, pp. 129-130
Open Access
Biologics for chronic rhinosinusitis with nasal polyposis: What should we do now without direct comparison trials?
Matthew A. Rank, Marcus Shaker
Annals of Allergy Asthma & Immunology (2022) Vol. 129, Iss. 2, pp. 136-137
Open Access
Matthew A. Rank, Marcus Shaker
Annals of Allergy Asthma & Immunology (2022) Vol. 129, Iss. 2, pp. 136-137
Open Access
